| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 163.81B | 169.09B | 159.96B | 154.56B | 153.35B | 131.12B |
| Gross Profit | 26.86B | 25.48B | 25.30B | 24.82B | 24.87B | 22.59B |
| EBITDA | 12.02B | 12.10B | 12.49B | 12.06B | 12.04B | 10.79B |
| Net Income | 6.15B | 5.70B | 6.53B | 6.17B | 6.70B | 5.74B |
Balance Sheet | ||||||
| Total Assets | 88.07B | 95.75B | 93.48B | 86.25B | 81.72B | 79.06B |
| Cash, Cash Equivalents and Short-Term Investments | 8.75B | 12.75B | 13.26B | 10.50B | 7.37B | 13.97B |
| Total Debt | 8.06B | 13.18B | 9.19B | 10.73B | 10.30B | 10.90B |
| Total Liabilities | 20.40B | 25.84B | 25.51B | 23.14B | 23.09B | 25.45B |
| Stockholders Equity | 67.67B | 69.90B | 67.97B | 63.11B | 58.62B | 53.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.00B | 5.89B | 4.70B | -3.47B | 1.40B |
| Operating Cash Flow | 0.00 | 5.07B | 7.33B | 7.72B | -1.21B | 3.62B |
| Investing Cash Flow | 0.00 | -2.87B | -849.00M | -2.88B | -1.62B | -3.19B |
| Financing Cash Flow | 0.00 | -2.71B | -3.42B | -2.00B | -2.77B | -2.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥811.01B | 19.74 | 19.13% | 2.64% | 9.45% | 12.93% | |
69 Neutral | ¥36.92B | 6.39 | ― | 5.21% | 5.71% | -11.71% | |
64 Neutral | ¥135.95B | 11.41 | ― | 2.82% | 13.31% | -11.40% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥52.52B | 11.80 | ― | 4.49% | 10.55% | -5.43% | |
53 Neutral | ¥274.97B | 17.73 | ― | 1.24% | 19.04% | 108.13% | |
49 Neutral | ¥3.43B | 21.74 | ― | 1.08% | -0.94% | ― |